BeiGene Raises $3.5 Billion in Shanghai STAR Board IPO
November 30, 2021 at 06:55 AM EST
Beijing 's BeiGene announced its Shanghai STAR Exchange IPO will raise $3.5 billion in gross proceeds for the company, more than the predictions of $3 billion. It is the third listing for the company, following NASDAQ and Hong Kong IPOs. The STAR Board shares, which represent 8.6% of BeiGene's total outstanding shares, are expected to begin trading on December 15. BeiGene develops medicines that are novel, affordable and improve treatment of serious diseases. Its portfolio includes more than 40 clinical candidates. More details.... Stock Symbols: (NSDQ: BGNE; HK: 06160) Share this with colleagues: // //
